Alberta Investment Management Corp (AIMCo)’s Ascendis Pharma A/S ASND Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,031	Closed	-$5.36M	–	1226
2023 Q1	$5.36M	Sell	50,031 -10,454	-17%	-$1.2M	0.05%	323
2022 Q4	$7.39M	Buy	60,485 +13,205	+28%	+$1.53M	0.07%	335
2022 Q3	$4.88M	Sell	47,280 -918	-2%	-$87K	0.04%	481
2022 Q2	$4.48M	Sell	48,198 -6,138	-11%	-$578K	0.03%	525
2022 Q1	$6.38M	Hold	54,336	–	–	0.04%	467
2021 Q4	$7.31M	Buy	+54,336	New	+$8.08M	0.04%	384

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ASND Position: Q2 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Ascendis Pharma A/S (ASND) in Q2 2023, closing a stake of 50,031 shares — an estimated $5.36M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ASND in Q4 2021 and held it in 6 quarters. The position peaked at $7.39M in Q4 2022. 158 funds tracked by Wall St. Rank hold ASND as of Q2 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Ascendis Pharma A/S position as of Q2 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 50,031 Ascendis Pharma A/S shares in Q2 2023, an estimated $5.36M.
Alberta Investment Management Corp (AIMCo) first reported a position in Ascendis Pharma A/S in Q4 2021 and held it in 6 quarters.
Alberta Investment Management Corp (AIMCo)'s Ascendis Pharma A/S position peaked at $7.39M in Q4 2022.
158 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2023, filed 14 Aug 2023.